Pharmacology of Desmin (low molecular weight Dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg)

By Dettori A.G.   Milani M.R.   Manotti C.   Zamboni V.   Palazzini E.   Barbanti M.  

Thrombosis Research, Vol. 79, Iss. 3, 1995-08 ,pp. : 249-260

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of Low Molecular Weight Dermatan Sulphate (Desmin) in Different Cohorts of Patients - An interactive graphic program for individual and population pharmacokinetic parameters estimation

By Saivin S.   Carrie D.   Escourrou J.   Duchene P.   Zamboni V.   Barbanti M.   Palazzini E.   Houin G.  

Thrombosis Research, Vol. 90, Iss. 3, 1998-05 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

PHARMACOLOGY OF A NEW LOW MOLECULAR WEIGHT DERMATAN SULPHATE (DESMIN) IN HEALTHY VOLUNTEERS: REPEATED DAILY INTRAMUSCULAR ADMINISTRATION OF 400 mg FOR A WEEK

By Dettori A.G.   Zamboni V.   Manotti C.   Canova N.   Barbanti M.   Palazzini E.  

Thrombosis Research, Vol. 83, Iss. 1, 1996-07 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin

By Peternel P.   Terbizan M.   Tratar G.   Bozic M.   Horvat D.   Salobir B.   Stegnar M.  

Thrombosis Research, Vol. 105, Iss. 3, 2002-02 ,pp. : 241-246

Elsevier

Access to resources Recommend Favorite

THROMBOLYSIS ENHANCING ACTIVITY OF A LOW MOLECULAR WEIGHT DERMATAN SULFATE (DESMIN 370) IN EXPERIMENTAL PULMONARY EMBOLISM IN RATS

By Colucci M.   Sardella L.   Barbanti M.   Calanni F.   Semeraro N.  

Thrombosis Research, Vol. 87, Iss. 5, 1997-09 ,pp. : 441-446

Elsevier

Access to resources Recommend Favorite